CD274 and neoplasm: To further assess the potential for enhancing the efficacy of ICB therapy on PDACs through PDNSC, we administered the anti-PDL1 (αPDL1) antibody to tumor-bearing mice because our previous study had reported the high-level PDL1 expression on the UN-KC-6141 tumors5.